<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7693102\results\search\disease\results.xml">
  <result pre="significantly decreasing the survival and proliferation of various types of" exact="cancer" post="cells. UNA has potential to exert inhibitory effects in"/>
  <result pre="a recent study highlighted the suppressive potential of UNA against" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2). Molecular modifications of UNA may enhance"/>
  <result pre="PHY906, which is used for adjuvant therapy of patients with" exact="cancer" post="[17,30,31]. It was reported that resins from Pistacia atlantica,"/>
  <result pre="UNA itself can exert therapeutic potential against diseases such as" exact="cancer" post="and infectious protozoa. 5. Anticancer Effects Cancer is a"/>
  <result pre="of death in the United States [42]. Major hallmarks of" exact="cancer" post="include sustained proliferation and inhibition of apoptosis, which can"/>
  <result pre="which can be accomplished by modulation of molecular mechanisms in" exact="cancer" post="cells [43]. Various cellular mechanisms of resistance to existing"/>
  <result pre="[45]. Previous studies consistently reported that UNA demonstrates cytotoxicity to" exact="cancer" post="cells originating from several tissue types (Figure 2). Ryu"/>
  <result pre="al. reported cytotoxic effects of UNA against A549 nonsmall cell" exact="lung cancer" post="(NSCLC) cells (IC50 = 7.7 Î¼M), SK-OV-3 ovarian cancer"/>
  <result pre="reported cytotoxic effects of UNA against A549 nonsmall cell lung" exact="cancer" post="(NSCLC) cells (IC50 = 7.7 Î¼M), SK-OV-3 ovarian cancer"/>
  <result pre="cell lung cancer (NSCLC) cells (IC50 = 7.7 Î¼M), SK-OV-3" exact="ovarian cancer" post="cells (IC50 = 32.1 Î¼M), SK-MEL-28 melanoma cells (IC50"/>
  <result pre="lung cancer (NSCLC) cells (IC50 = 7.7 Î¼M), SK-OV-3 ovarian" exact="cancer" post="cells (IC50 = 32.1 Î¼M), SK-MEL-28 melanoma cells (IC50"/>
  <result pre="Î¼M), XF498 glioblastoma cells (IC50 = 25.9 Î¼M), and HCT15" exact="colon cancer" post="cell lines (IC50 = 4.6 Î¼M) [46]. In other"/>
  <result pre="XF498 glioblastoma cells (IC50 = 25.9 Î¼M), and HCT15 colon" exact="cancer" post="cell lines (IC50 = 4.6 Î¼M) [46]. In other"/>
  <result pre="other studies, UNA effectively exerted antiproliferative effects in HONE-1 nasopharyngeal" exact="cancer" post="cells, KB oral epidermoid cancer cells, and HT29 colorectal"/>
  <result pre="antiproliferative effects in HONE-1 nasopharyngeal cancer cells, KB oral epidermoid" exact="cancer" post="cells, and HT29 colorectal cancer cells with low IC50"/>
  <result pre="nasopharyngeal cancer cells, KB oral epidermoid cancer cells, and HT29" exact="colorectal cancer" post="cells with low IC50 values of 5.2 Î¼M, 4.0"/>
  <result pre="cancer cells, KB oral epidermoid cancer cells, and HT29 colorectal" exact="cancer" post="cells with low IC50 values of 5.2 Î¼M, 4.0"/>
  <result pre="(IC50 = 23.6 Î¼M) and H460 (IC50 = 17.6 Î¼M)" exact="lung cancer," post="and Jurkat (IC50 = 23.9 Î¼M), K562 (IC50 ="/>
  <result pre="(IC50 = 12.8 Î¼M), and K562-Lucena 1(IC50 = 12.6 Î¼M)" exact="leukemia" post="cells in vitro [47]. These results were comparable with"/>
  <result pre="were comparable with the IC50 values of ULA in same" exact="cancer" post="cells, which were 8.8 Î¼M, 8.2 Î¼M, and 4.7"/>
  <result pre="respectively [20]. Cytotoxicity of UNA was also shown in other" exact="cancer" post="cells, including B16F0 murine melanoma (IC50 = 19.8 Î¼M),"/>
  <result pre="including B16F0 murine melanoma (IC50 = 19.8 Î¼M), L1210 murine" exact="leukemia" post="(IC50 = 6.9 Î¼M), SK-MEL-2 human melanoma (IC50 ="/>
  <result pre="SK-MEL-2 human melanoma (IC50 = 7.6 Î¼M), and HL60 human" exact="leukemia" post="cells (IC50 = 54.9 Î¼M) [24,48,49]. UNA significantly increased"/>
  <result pre="[24,48,49]. UNA significantly increased survival days of mice bearing S180" exact="sarcoma" post="cells by seven days compared to nontreated mice, and"/>
  <result pre="of topoisomerase-I (IC50 = 5.5 mM), one of targets for" exact="cancer" post="treatment [48,50]. Furthermore, UNA isolated from Toona sinensis reduced"/>
  <result pre="UNA isolated from Toona sinensis reduced the viability of several" exact="cancer" post="cell lines and induced apoptosis of MGC-803 gastric cancer"/>
  <result pre="several cancer cell lines and induced apoptosis of MGC-803 gastric" exact="cancer" post="cells and PC3 prostate cancer cells [35]. Noticeably, UNA"/>
  <result pre="and induced apoptosis of MGC-803 gastric cancer cells and PC3" exact="prostate cancer" post="cells [35]. Noticeably, UNA exerted a relatively weaker cytotoxic"/>
  <result pre="induced apoptosis of MGC-803 gastric cancer cells and PC3 prostate" exact="cancer" post="cells [35]. Noticeably, UNA exerted a relatively weaker cytotoxic"/>
  <result pre="cells (IC50 &amp;gt; 50â€‰Î¼M), whereas the IC50 of UNA on" exact="cancer" post="cells ranged from 13.6 Î¼M to 26.5 Î¼M, suggesting"/>
  <result pre="Î¼M, suggesting that UNA can selectively reduce the survival of" exact="cancer" post="cells while minimizing side effects against normal cells. UNA"/>
  <result pre="tumors, it is expected that UNA may facilitate chemotherapy of" exact="cancer" post="by targeting cathepsin B of cancer cells [52]. In"/>
  <result pre="may facilitate chemotherapy of cancer by targeting cathepsin B of" exact="cancer" post="cells [52]. In studies regarding both UNA and ULA,"/>
  <result pre="stronger than, those of ULA [20,24,35,46,47,48,49,53,54]. Of note, in HCT15" exact="colon cancer" post="cells, the effective dose of UNA to exert cytotoxicity"/>
  <result pre="than, those of ULA [20,24,35,46,47,48,49,53,54]. Of note, in HCT15 colon" exact="cancer" post="cells, the effective dose of UNA to exert cytotoxicity"/>
  <result pre="has strong antitumor potential comparable with ULA. Metastasis occurs when" exact="cancer" post="cells from primary tumors spread to other organs. Metastasis"/>
  <result pre="tumors spread to other organs. Metastasis is often fatal to" exact="cancer" post="patients, as it is responsible for approximately 66.7% of"/>
  <result pre="cancer patients, as it is responsible for approximately 66.7% of" exact="cancer" post="deaths [55]. The extracellular matrix (ECM) holds cancer cells"/>
  <result pre="66.7% of cancer deaths [55]. The extracellular matrix (ECM) holds" exact="cancer" post="cells to the origin of oncogenesis as a biochemical"/>
  <result pre="origin of oncogenesis as a biochemical and biophysical obstacle. For" exact="cancer" post="cells to reach out to a great distance throughout"/>
  <result pre="cell migration nonproteolytically via their hemopexin domain. Therefore, metastasis of" exact="cancer" post="is accelerated by migration and invasion, which can be"/>
  <result pre="as ULA also hampered invasion and expression of MMPs in" exact="lung cancer" post="cells [60]. Taken together, UNA can be inferred to"/>
  <result pre="ULA also hampered invasion and expression of MMPs in lung" exact="cancer" post="cells [60]. Taken together, UNA can be inferred to"/>
  <result pre="has the potential to treat various human diseases other than" exact="cancer" post="(Figure 3). Protozoa are composed of a wide range"/>
  <result pre="and other intestinal protozoal diseases, such as amoebic dysentery and" exact="toxoplasmosis" post="[61]. Protozoan-related diseases account for substantial morbidity and mortality,"/>
  <result pre="against Leishmania species, a protozoan that causes the tropical disease" exact="leishmaniasis" post="[65]. UNA selectively repressed the proteinase activity of cathepsin"/>
  <result pre="Acanthamoeba Griffini (IC50 = 11.1 ÂµM), which can cause Acanthamoeba" exact="keratitis" post="and granulomatous amebic encephalitis [67]. This study was notable"/>
  <result pre="11.1 ÂµM), which can cause Acanthamoeba keratitis and granulomatous amebic" exact="encephalitis" post="[67]. This study was notable in that there was"/>
  <result pre="concentrations. 7. Antihyperglycemic Effects Hyperglycemia, which is highly associated with" exact="diabetes mellitus" post="and acute stress, is a condition in which cellular"/>
  <result pre="as this can impair immune responses, promote inflammation, and worsen" exact="cancer" post="progression [71,72]. Pentacyclic triterpenoids have the potential to control"/>
  <result pre="Î±-glucosidase of bakerâ€™s yeast (IC50 = 2.47 ÂµM), and this" exact="suppression" post="was significantly stronger than that by ULA (IC50 ="/>
  <result pre="While inflammation is responsible for numerous diseases, including arthritis, diabetes," exact="multiple sclerosis," post="Alzheimerâ€™s disease, and Parkinsonâ€™s disease, it is also highly"/>
  <result pre="disease, and Parkinsonâ€™s disease, it is also highly associated with" exact="cancer" post="progression [6,79]. Anti-inflammatory effects of triterpenoids from medicinal plants"/>
  <result pre="as well. In previous research, UNA suppressed cytopathic effects of" exact="herpes simplex" post="virus types I and II infecting Vero monkey kidney"/>
  <result pre="the inhibitory effect of UNA (IC50 = 17.6 ÂµM) against" exact="herpes simplex" post="virus type I was stronger than the antiviral effect"/>
  <result pre="(EBV) early antigen induction and cytotoxicity of ULA in Rajiâ€&quot;Burkittâ€™s" exact="lymphoma" post="cells [85]. While ULA inhibited about 20% of EBV"/>
  <result pre="demonstrated that UNA has the potential to strongly interact with" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) Nsp15, an endoribonuclease which is essential"/>
  <result pre="oxygen species (ROS), can affect various cellular events such as" exact="cancer" post="proliferation, inflammation, and aging [89]. Some studies conducted assays"/>
  <result pre="a previous report, UNA effectively reduced ROS levels of HL60" exact="leukemia" post="cells (IC50 = 55 ÂµM), although this effect was"/>
  <result pre="proliferation and apoptosis, MAPKs are one of major targets for" exact="cancer" post="treatment. The demonstrated anticancer effects of UNA, which were"/>
  <result pre="sufficiently explained. Two publications previously explained the signaling pathways of" exact="cancer" post="cells regulated by UNA (Figure 4). In MGC-803 human"/>
  <result pre="cells regulated by UNA (Figure 4). In MGC-803 human gastric" exact="cancer" post="cells, UNA increased the protein levels of p53, cell"/>
  <result pre="execute apoptosis of cells [35]. In A549 and H1299 human" exact="lung cancer" post="cells, UNA inactivated phosphorylation extracellular signal-regulated kinase (ERK) and"/>
  <result pre="apoptosis of cells [35]. In A549 and H1299 human lung" exact="cancer" post="cells, UNA inactivated phosphorylation extracellular signal-regulated kinase (ERK) and"/>
  <result pre="signaling pathways in some contexts, such as cytotoxicity in HCT15" exact="colon cancer" post="cells (IC50 = 1.23 Î¼M) and attenuated NO production"/>
  <result pre="pathways in some contexts, such as cytotoxicity in HCT15 colon" exact="cancer" post="cells (IC50 = 1.23 Î¼M) and attenuated NO production"/>
  <result pre="of UNA (2Î±/2Î²-bromo UNA) showed cytotoxicity in various types of" exact="cancer" post="cells, such as CCRPâ€&quot;CEM leukemia cells (IC50 = 3.6"/>
  <result pre="cytotoxicity in various types of cancer cells, such as CCRPâ€&quot;CEM" exact="leukemia" post="cells (IC50 = 3.6 ÂµM), and induced cellular apoptosis,"/>
  <result pre="factor-Î± (TNF-Î±)-induced nuclear factor-kappa B (NF-ÎºB) activation of H460 human" exact="lung cancer" post="cells, with values of IC50 ranging from 0.94 to"/>
  <result pre="(TNF-Î±)-induced nuclear factor-kappa B (NF-ÎºB) activation of H460 human lung" exact="cancer" post="cells, with values of IC50 ranging from 0.94 to"/>
  <result pre="were well explained [19]. Since there are diverse types of" exact="cancer" post="cells suppressed by UNA, in vivo experiments using tumor"/>
  <result pre="factor-ÎºB IPP Isopentenyl diphosphate DMAPP Dimethylallyl diphosphate NSCLC Nonsmall cell" exact="lung cancer" post="MMP Matrix metalloproteinase NO Nitric oxide LPS Lipopolysaccharide EBV"/>
  <result pre="IPP Isopentenyl diphosphate DMAPP Dimethylallyl diphosphate NSCLC Nonsmall cell lung" exact="cancer" post="MMP Matrix metalloproteinase NO Nitric oxide LPS Lipopolysaccharide EBV"/>
  <result pre="1.PetrovskaB.B.Historical review of medicinal plantsâ€™ usagePharm. Rev.201261510.4103/0973-7847.9584922654398 2.DesaiA.G.QaziG.N.GanjuR.K.El-TamerM.SinghJ.SaxenaA.K.BediY.S.TanejaS.C.BhatH.K.Medicinal plants and" exact="cancer" post="chemopreventionCurr. Drug Metab.2008958159110.2174/13892000878582165718781909 3.WinkM.Modes of Action of Herbal Medicines"/>
  <result pre="8.YanS.L.HuangC.Y.WuS.T.YinM.C.Oleanolic acid and ursolic acid induce apoptosis in four human" exact="liver cancer" post="cell linesToxicol. In Vitro20102484284810.1016/j.tiv.2009.12.00820005942 9.IkedaY.MurakamiA.OhigashiH.Ursolic acid: An anti- and"/>
  <result pre="acid and ursolic acid induce apoptosis in four human liver" exact="cancer" post="cell linesToxicol. In Vitro20102484284810.1016/j.tiv.2009.12.00820005942 9.IkedaY.MurakamiA.OhigashiH.Ursolic acid: An anti- and"/>
  <result pre="high-fat dietInt. Immunopharmacol.2009911311910.1016/j.intimp.2008.10.01319013541 12.KongL.LiS.LiaoQ.ZhangY.SunR.ZhuX.ZhangQ.WangJ.WuX.FangX.et al.Oleanolic acid and ursolic acid: Novel" exact="hepatitis" post="C virus antivirals that inhibit NS5B activityAntivir. Res.201398445310.1016/j.antiviral.2013.02.00323422646 13.ChoiW.H.LeeI.A.Evaluation"/>
  <result pre="Med. Chem.20193495597210.1080/14756366.2019.1605364 27.FontanaG.BrunoM.NotarbartoloM.LabbozzettaM.PomaP.SpinellaA.RosselliS.Cytotoxicity of oleanolic and ursolic acid derivatives toward" exact="hepatocellular carcinoma" post="and evaluation of NF-kappaB involvementBioorg. Chem.20199010305410.1016/j.bioorg.2019.10305431212180 28.CHENB.-l.FENGK.ZHENGZ.-h.CHENY.-y.Determination of Oleanic"/>
  <result pre="Anal.2009491296130210.1016/j.jpba.2009.03.00619359121 31.LiuS.H.ChengY.C.Old formula, new Rx: The journey of PHY906 as" exact="cancer" post="adjuvant therapyJ. Ethnopharmacol.201214061462310.1016/j.jep.2012.01.04722326673 32.MahjoubF.Akhavan RezayatK.YousefiM.MohebbiM.SalariR.Pistacia atlantica Desf. A review"/>
  <result pre="and apoptosis-inducing mechanism of constituents from Toona sinensis on human" exact="cancer" post="cellsCancer Cell Int.2013131210.1186/1475-2867-13-1223394678 36.SaeedS.A.FarnazS.SimjeeR.U.MalikA.Triterpenes and B-sitosterol from piper betle:"/>
  <result pre="triterpenes from Crataegus pinnatifidaArch. Pharm. Res.20002315515810.1007/BF0297550510836742 50.HevenerK.VerstakT.A.LutatK.E.RiggsbeeD.L.MooneyJ.W.Recent developments in topoisomerase-targeted" exact="cancer" post="chemotherapyActa Pharm. Sin. B2018884486110.1016/j.apsb.2018.07.00830505655 51.de SousaL.R.F.WuH.M.NeboL.FernandesJ.B.da SilvaM.F.D.F.KieferW.SchirmeisterT.VieiraP.C.Natural products as"/>
  <result pre="acid derivativesZ. FÃ¼r Nat. B20136820120610.5560/znb.2013-2261 55.DillekasH.RogersM.S.StraumeO.Are 90% of deaths from" exact="cancer" post="caused by metastases?Cancer Med.201985574557610.1002/cam4.247431397113 56.Bravo-CorderoJ.J.HodgsonL.CondeelisJ.Directed cell invasion and migration"/>
  <result pre="during metastasisCurr. Opin. Cell Biol.20122427728310.1016/j.ceb.2011.12.00422209238 57.GialeliC.TheocharisA.D.KaramanosN.K.Roles of matrix metalloproteinases in" exact="cancer" post="progression and their pharmacological targetingFEBS J.2011278162710.1111/j.1742-4658.2010.07919.x21087457 58.DufourA.SampsonN.S.ZuckerS.CaoJ.Role of the"/>
  <result pre="cell proliferation, invasion and migration by ursolic acid in human" exact="lung cancer" post="cell linesToxicol. In Vitro2011251274128010.1016/j.tiv.2011.04.01421539908 61.CapelaR.MoreiraR.LopesF.An Overview of Drug Resistance"/>
  <result pre="proliferation, invasion and migration by ursolic acid in human lung" exact="cancer" post="cell linesToxicol. In Vitro2011251274128010.1016/j.tiv.2011.04.01421539908 61.CapelaR.MoreiraR.LopesF.An Overview of Drug Resistance"/>
  <result pre="Activity in Medicinal Chemistry StudiesLett. Org. Chem.20129929510.2174/157017812800221708 70.InzucchiS.E.BergenstalR.M.BuseJ.B.DiamantM.FerranniniE.NauckM.PetersA.L.TsapasA.WenderR.MatthewsD.R.et al.Management of" exact="hyperglycemia" post="in type 2 diabetes: A patient-centered approach: Position statement"/>
  <result pre="Potential Antidiabetic AgentPLoS ONE201510e013876710.1371/journal.pone.013876726406581 78.LeeJ.YeeS.T.KimJ.J.ChoiM.S.KwonE.Y.SeoK.I.LeeM.K.Ursolic acid ameliorates thymic atrophy and" exact="hyperglycemia" post="in streptozotocin-nicotinamide-induced diabetic miceChem. Biol. Interact.201018863564210.1016/j.cbi.2010.09.01920869956 79.CoussensL.M.WerbZ.Inflammation and cancerNature200242086086710.1038/nature0132212490959"/>
  <result pre="in CancerCancers201911161810.3390/cancers11101618 94.GaoJ.ZhuH.WanH.ZouX.MaX.GaoG.Harmine suppresses the proliferation and migration of human" exact="ovarian cancer" post="cells through inhibiting ERK/CREB pathwayOncol. Rep.2017382927293410.3892/or.2017.595228901502 95.ChengH.L.HsiehM.J.YangJ.S.LinC.W.LueK.H.LuK.H.YangS.F.Nobiletin inhibits human"/>
  <result pre="CancerCancers201911161810.3390/cancers11101618 94.GaoJ.ZhuH.WanH.ZouX.MaX.GaoG.Harmine suppresses the proliferation and migration of human ovarian" exact="cancer" post="cells through inhibiting ERK/CREB pathwayOncol. Rep.2017382927293410.3892/or.2017.595228901502 95.ChengH.L.HsiehM.J.YangJ.S.LinC.W.LueK.H.LuK.H.YangS.F.Nobiletin inhibits human"/>
  <result pre="cancer cells through inhibiting ERK/CREB pathwayOncol. Rep.2017382927293410.3892/or.2017.595228901502 95.ChengH.L.HsiehM.J.YangJ.S.LinC.W.LueK.H.LuK.H.YangS.F.Nobiletin inhibits human" exact="osteosarcoma" post="cells metastasis by blocking ERK and JNK-mediated MMPs expressionOncotarget20167352083522310.18632/oncotarget.910627144433"/>
  <result pre="96.TangF.TangS.GuoX.YangC.JiaK.CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of" exact="lung cancer" post="cells by downregulating the ERK/CREB signaling pathwayMol. Med. Rep.2017166708671410.3892/mmr.2017.746628901509"/>
  <result pre="siRNA silencing suppresses the proliferation, metastasis and invasion of lung" exact="cancer" post="cells by downregulating the ERK/CREB signaling pathwayMol. Med. Rep.2017166708671410.3892/mmr.2017.746628901509"/>
  <result pre="It was reported that UNA inhibited proliferation of HONE-1 nasopharyngeal" exact="cancer" post="cells, KB oral epidermal cancer cells, HT29 colorectal cancer"/>
  <result pre="inhibited proliferation of HONE-1 nasopharyngeal cancer cells, KB oral epidermal" exact="cancer" post="cells, HT29 colorectal cancer cells, nonsmall cell lung cancer"/>
  <result pre="HONE-1 nasopharyngeal cancer cells, KB oral epidermal cancer cells, HT29" exact="colorectal cancer" post="cells, nonsmall cell lung cancer (NSCLC) (A549, H460) cells,"/>
  <result pre="nasopharyngeal cancer cells, KB oral epidermal cancer cells, HT29 colorectal" exact="cancer" post="cells, nonsmall cell lung cancer (NSCLC) (A549, H460) cells,"/>
  <result pre="oral epidermal cancer cells, HT29 colorectal cancer cells, nonsmall cell" exact="lung cancer" post="(NSCLC) (A549, H460) cells, and leukemia (Jurkat, K562, HL60,"/>
  <result pre="epidermal cancer cells, HT29 colorectal cancer cells, nonsmall cell lung" exact="cancer" post="(NSCLC) (A549, H460) cells, and leukemia (Jurkat, K562, HL60,"/>
  <result pre="cells, nonsmall cell lung cancer (NSCLC) (A549, H460) cells, and" exact="leukemia" post="(Jurkat, K562, HL60, and K562-Lucena 1) cells. UNA showed"/>
  <result pre="cells. UNA showed cytotoxic effects in A549 NSCLC cells, SK-OV-3" exact="ovarian cancer" post="cells, SK-MEL-2 melanoma cells, SK-MEL-28 melanoma cells, XF498 glioblastoma"/>
  <result pre="UNA showed cytotoxic effects in A549 NSCLC cells, SK-OV-3 ovarian" exact="cancer" post="cells, SK-MEL-2 melanoma cells, SK-MEL-28 melanoma cells, XF498 glioblastoma"/>
  <result pre="SK-MEL-2 melanoma cells, SK-MEL-28 melanoma cells, XF498 glioblastoma cells, HCT15" exact="colon cancer" post="cells, and HL60 leukemia cells. UNA also induced apoptosis"/>
  <result pre="melanoma cells, SK-MEL-28 melanoma cells, XF498 glioblastoma cells, HCT15 colon" exact="cancer" post="cells, and HL60 leukemia cells. UNA also induced apoptosis"/>
  <result pre="cells, XF498 glioblastoma cells, HCT15 colon cancer cells, and HL60" exact="leukemia" post="cells. UNA also induced apoptosis in MGC-803 gastric cancer"/>
  <result pre="HL60 leukemia cells. UNA also induced apoptosis in MGC-803 gastric" exact="cancer" post="cells and PC3 prostate cancer cells. Most recently, antimetastatic"/>
  <result pre="also induced apoptosis in MGC-803 gastric cancer cells and PC3" exact="prostate cancer" post="cells. Most recently, antimetastatic effects of UNA were reported"/>
  <result pre="induced apoptosis in MGC-803 gastric cancer cells and PC3 prostate" exact="cancer" post="cells. Most recently, antimetastatic effects of UNA were reported"/>
  <result pre="and Plasmodium falciparum. UNA also has the possibility of improving" exact="hyperglycemia" post="via inhibition of Î±-glycosidase and glycogen phosphorylase and stimulation"/>
  <result pre="the metabolism of SARS-CoV-2. UNA also exerts inhibitory effects in" exact="herpes simplex" post="type I and II and Epsteinâ€&quot;Barr viruses. Moreover, antioxidant"/>
  <result pre="through the mediation of the mitochondria pathway in MGC-803 gastric" exact="cancer" post="cells. On the other hand, UNA exerts antimetastatic effects"/>
  <result pre="signaling pathway, leading to the inhibition of MMP-1 and possible" exact="suppression" post="of skin aging."/>
 </snippets>
</snippetsTree>
